rrd207402_234375.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q5QO0OSACvxpZ4IvL2TBn2QcM7LqEouS4xiAN0QQH3XQAJYXneUQ3V8nex3vbIWe rLLfp9MflYCgVJd4/6/0cg== 0001181431-09-006274.txt : 20090203 0001181431-09-006274.hdr.sgml : 20090203 20090203183806 ACCESSION NUMBER: 0001181431-09-006274 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090130 FILED AS OF DATE: 20090203 DATE AS OF CHANGE: 20090203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ehrlich Christopher B CENTRAL INDEX KEY: 0001293973 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51967 FILM NUMBER: 09566310 BUSINESS ADDRESS: BUSINESS PHONE: 650 854 8585 MAIL ADDRESS: STREET 1: C/O INTERWEST PARTNERS STREET 2: 2710 SAND HILL ROAD, 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: (510) 215-3500 MAIL ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 3 1 rrd231411.xml FORM 3 X0203 3 2009-01-30 1 0001178711 Transcept Pharmaceuticals Inc TSPT 0001293973 Ehrlich Christopher B C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD., SUITE #110 POINT RICHMOND CA 94804 1 0 0 0 No securities are beneficially owned. /s/ Marilyn E. Wortzman, by power of attorney 2009-02-02 EX-24. 2 rrd207402_234375.htm POWER OF ATTORNEY rrd207402_234375.html

                                                                      Exhibit 24
                                POWER OF ATTORNEY

        The undersigned, as a Section 16 reporting person of Transcept
Pharmaceuticals, Inc. (the "Company"), hereby constitutes and appoints Robert J.
Bulka, Thomas P. Soloway and Marilyn E. Wortzman, the undersigned's true and
lawful attorneys-in-fact to:

        1.      complete and execute Forms 3, 4 and 5 and other forms and all
                amendments thereto as such attorneys-in-fact shall in their
                discretion determine to be required or advisable pursuant to
                Section 16 of the Securities Exchange Act of 1934 (as amended)
                and the rules and regulations promulgated thereunder, or any
                successor laws and regulations, as a consequence of the
                undersigned's ownership, acquisition or disposition of
                securities of the Company; and

        2.      do all acts necessary in order to file such forms with the
                Securities and Exchange Commission, any securities exchange or
                national association, the Company and such other person or
                agency as the attorneys-in-fact shall deem appropriate.

        The undersigned hereby ratifies and confirms all that said
attorneys-in-fact and agent shall do or cause to be done by virtue hereof. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, is not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934 (as amended).

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 23rd day of January, 2009.

                             Signature: /s/ Christopher B. Ehrlich
                                        ---------------------------------------

                            Print Name: Christopher B. Ehrlich
                                        ---------------------------------------

-----END PRIVACY-ENHANCED MESSAGE-----